Dr. Mark D. Sherman, MD

Dr. Sherman practices at SAC Health - Norton in San Bernardino, California.

Dr. Sherman's NPI, 1326056235, was assigned on August 4, 2006. Dr. Sherman graduated from Albert Einstein College of Medicine in 1985. Dr. Sherman's California license number on file is H69829.

Dr. Sherman's primary practice is SAC Health - Norton, at 1454 E. Second St, San Bernardino, CA 92408 in San Bernardino County. The practice phone is (909) 382-7180.

Dr. Sherman's primary practice is SAC Health - Norton in San Bernardino, California. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Sherman to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Sherman's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sherman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Sherman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Sherman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Sherman's licenses on file in 2 states: California and Arizona.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Sherman treats.

CMS data shows 34 Medicare services from Dr. Sherman across 2 procedure codes in 2024, for 38 Medicare patients. Medicare paid $2,708 for them. Every service was in an office.

CMS counts 38 Medicare patients who saw Dr. Sherman in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sherman's median patient age at 59, with 64% women.

In 2024, Dr. Sherman wrote 805 Medicare Part D claims for 236 patients. 59% of them were for generic drugs. CMS names the drug for 672 of them, across 16 drugs with 11 or more claims each, at $79,624 in total drug cost. In 2023, CMS named 1,655 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Sherman for performance year 2024, reported as part of a group. Dr. Sherman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Sherman in 2024. The most frequent topics are Biopsy, Muramidase and Sjogren's Syndrome. Dr. Sherman has published most often in Am J Ophthalmol. Dr. Sherman's most frequent co-authors are Shirin M. Farahmand, MD, John P. Whitcher, MD and Keith H. Baratz, MD.

CMS Open Payments shows 94 general payments to Dr. Sherman from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Abbvie Inc. paid the most, $40,367.

Dmand AI lists 1 award for Dr. Sherman.

Dr. Sherman graduated from Albert Einstein College of Medicine in 1985. Dr. Sherman is a member of AAO.

Dr. Sherman is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.